Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2260
-0.0050 (-2.16%)
At close: Dec 24, 2025
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €15.83 million as of December 26, 2025. Its market cap has decreased by -17.41% in one year.
Market Cap
15.83M
Enterprise Value
17.39M
Revenue
3.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.23
Market Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 15.83M, a decrease of -78.80%. That is a compound annual growth rate of -18.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 15.83M | -13.42% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | 21.78M | -72.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.68B |
| Laboratorios Farmaceuticos Rovi | 3.21B |
| Almirall | 2.75B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 763.78M |
| Oryzon Genomics | 250.75M |
| Prim, S.A. | 224.61M |